At Cellectricon, we create new avenues for neuroscience drug discovery. Our mission is to create outstanding value for our Clients through highly customized in vitro neurobiology services delivering scientific excellence, innovation, and quality of the highest of standards.

With a broad platform for in vitro neurobiology research, we help you to:

•	Accelerate your early R&D process and reduce your time-to-decision making
•	Obtain novel insights into disease biology and identify targets and lead compounds with potential to produce first-in-class medicines
•	Benefit from truly collaborative services where scientific exchange and open communication are prioritized to ensure project success


Our unique discovery platform combines drug discovery expertise and disease area knowledge with cutting-edge technologies. With the platform, we create complex disease models and assays for functional and morphological screening.

We have established service modules in the areas of Neuroinflammation, Peripheral Neuropathies, Neurodegeneration and Neuroplasticity. Through our services, we can accelerate your target and lead discovery programs.

Biotechnology

Health Care

Life Sciences

Neuroscience

Pharmaceutical

Cellectricon

The Mölndal office focuses on biomedicine and pharmacology through external collaborations and strategic business operations.

Mölndal

Mattias Karlsson

Paul Karila

Johan Pihl

This department is responsible for managing partnerships and collaborations with external organizations.

External Collaborations

This department oversees the strategic direction and overall management of the organization.

Executive Leadership

This department focuses on advancing scientific knowledge and innovation in biomedicine and pharmacology.

Cellectricon

Org chart

Teams

External Collaborations

Executive Leadership

Research and Development

Offices

Cellectricon

Org chart

Teams

External Collaborations

Executive Leadership

Research and Development

Offices

Related companies